Brazil’s Eurofarma launched Axon Ventures, a US$12m CVC fund to invest in early-stage healthcare startups in Brazil. Eurofarma’s head of corporate venture, Paulo Braga, will lead the effort.

(Crunchbase) Brazilian pharmaceutical giant Eurofarma has launched a venture arm called Axon Ventures to invest in early-stage healthcare companies, Crunchbase News has learned exclusively.

In a phone interview, Paulo Braga – the company’s head of corporate venture – told me that the fund will allocate up to Brazilian Real(R) $45 million (about US $12 million) “for technology projects with the potential to transform the healthcare sector.”

Read more at Crunchbase.